A new Ebola drug grown from special tobacco plants has been shown to cure monkeys that were already displaying signs of infection by the viral hemorrhagic fever, the Los Angeles Times reported on Wednesday.
Other Ebola countermeasures have been shown to work on infected animals before they start displaying symptoms of the highly virulent and lethal disease. However, this is the first time a drug has demonstrated any effectiveness after signs of the virus have manifested. That is regarded as a crucial capability in the event of a real-life disease epidemic, according to virologist Gene Olinger, who works at the Army Medical Research Institute of Infectious Diseases at Fort Detrick, Md.
“We’ve pushed the opportunity to treat people to the point where they walk in and say, ‘I have a fever,’” said Olinger, co-author of a report on the new Ebola drug published by the Science Translational Medicine journal on Wednesday. “A lot of folks in the field would have thought protecting an animal at the time of fever and viremia is too late to have a clinical benefit.”
Ebola is one of the most deadly and contagious diseases known to exist in nature. The lack of adequate vaccines and antidotes for the disease have made it a serious worry for biodefense specialists concerned about its possible applications as a biological weapon.
In the recent study, seven infected rhesus monkeys were administered the experimental treatment MB-003 through their veins once every three days. Three of the monkeys did not die, resulting in a statistically notable success rate of 43 percent.
Fort Detrick scientist and lead study author James Pettitt said it is probable that in a real-life outbreak, the drug would be administered at a higher dosage and with greater frequency.
“We think we’ll get better results,” the researcher said.
Growing the drug from specially developed tobacco leaves is not only less costly than conventional cell-based methods, but also allows for large batches of the drug to be produced on fairly short, weeklong schedules, according to the Times article.
Olinger said further measures will be taken to improve MB-003 by adding to it more Ebola antibodies that were discovered by a different group of researchers.
What We're Following See More »
Foreign Policy takes a look at the future of mining the estimated "100,000 near-Earth objects—including asteroids and comets—in the neighborhood of our planet. Some of these NEOs, as they’re called, are small. Others are substantial and potentially packed full of water and various important minerals, such as nickel, cobalt, and iron. One day, advocates believe, those objects will be tapped by variations on the equipment used in the coal mines of Kentucky or in the diamond mines of Africa. And for immense gain: According to industry experts, the contents of a single asteroid could be worth trillions of dollars." But the technology to get us there is only the first step. Experts say "a multinational body might emerge" to manage rights to NEOs, as well as a body of law, including an international court.
Not to be outdone by Jeffrey Goldberg's recent piece in The Atlantic about President Obama's foreign policy, the New York Times Magazine checks in with a longread on the president's economic legacy. In it, Obama is cognizant that the economic reality--73 straight months of growth--isn't matched by public perceptions. Some of that, he says, is due to a constant drumbeat from the right that "that denies any progress." But he also accepts some blame himself. “I mean, the truth of the matter is that if we had been able to more effectively communicate all the steps we had taken to the swing voter,” he said, “then we might have maintained a majority in the House or the Senate.”
Ronald Reagan's children and political allies took to the media and Twitter this week to chide funnyman Will Ferrell for his plans to play a dementia-addled Reagan in his second term in a new comedy entitled Reagan. In an open letter, Reagan's daughter Patti Davis tells Ferrell, who's also a producer on the movie, “Perhaps for your comedy you would like to visit some dementia facilities. I have—I didn’t find anything comedic there, and my hope would be that if you’re a decent human being, you wouldn’t either.” Michael Reagan, the president's son, tweeted, "What an Outrag....Alzheimers is not joke...It kills..You should be ashamed all of you." And former Rep. Joe Walsh called it an example of "Hollywood taking a shot at conservatives again."
In a sign that she’s ready to put a longer-than-expected primary battle behind her, former Secretary of State Hillary Clinton (D) is no longer going on the air in upcoming primary states. “Team Clinton hasn’t spent a single cent in … California, Indiana, Kentucky, Oregon and West Virginia, while” Sen. Bernie Sanders’ (I-VT) “campaign has spent a little more than $1 million in those same states.” Meanwhile, Sen. Jeff Merkley (D-OR), Sanders’ "lone backer in the Senate, said the candidate should end his presidential campaign if he’s losing to Hillary Clinton after the primary season concludes in June, breaking sharply with the candidate who is vowing to take his insurgent bid to the party convention in Philadelphia.”